Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE”

783 pharma patents match "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 783
Index total 30,257
Page 23 / 33

Quick answer

This filtered view shows 783 pharmaceutical patents matching "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

783 results for “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE” · 30,257 patents in full index Clear search

  1. US 7510715

    Protozoan derived compositions and methods of use thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  2. US 7504096

    Methods for in vitro fertilization

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted
  3. US 7504109

    Influenza hemagglutinin and neuraminidase variants

    The United States of America as Represented by The Department of Health Services, National Institute of Health · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted
  4. US 7494980

    Antimicrobial peptide and methods of use thereof

    The United States of America as represented by the Secretary of the Army · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  5. US 7488808

    Janus family kinases and identification of immune modulators

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted
  6. US 7485709

    Identification of a novel BHD gene

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted
  7. US 7485306

    Lutzomyia longipalpis polypeptides and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted
  8. US 7455994

    Methods for producing Marburg virus proteins

    The United States of America as represented by the Secretary of the Army · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  9. US 7432236

    Vasostatin as marrow protectant

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  10. US 7432067

    Methods of detection of MATER protein autoantibodies

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted
  11. US 7427394

    Biodegradable poly(β-amino esters) and uses thereof

    The United States of America as represented by the Secretary of the Army · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  12. US 7427598

    Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  13. US 7427590

    Neurothrophic components of the ADNF I complex

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted
  14. US 7425611

    Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 16, 2008 · Expires Sep 11, 2028

    granted
  15. US 7419957

    Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  16. US 7419683

    Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules

    The United States of America as represented by the Secretary of the Army · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  17. US 7416878

    Immunogenic compositions including rough phenotype Brucella host strains and complementation DNA fragments

    The United States of America as represented by the Secretary of the Army · Granted Aug 26, 2008 · Expires Aug 21, 2028

    granted
  18. US 7407935

    Ricin toxin A-chain fragment for use as a vaccine

    The United States of America as represented by the Secretary of the Army · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted
  19. US 7407658

    Vaccines for blocking transmission of plasmodium vivax

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted
  20. US 7407664

    Peptide vaccines against group A streptococci

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted
  21. US 7404961

    Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins

    The United States of America as represented by the Secretary of the Army · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted
  22. US 7402567

    Treatment of disease by inducing cell apoptosis

    The United States of America as represented by the Department of Veterans Affairs, Office of the General Counsel (024) · Granted Jul 22, 2008 · Expires Jul 17, 2028

    granted
  23. US 7378097

    Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant

    The United States of America as represented by the Secretary of the Army · Granted May 27, 2008 · Expires May 22, 2028

    granted
  24. US 7378257

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted May 27, 2008 · Expires May 22, 2028

    granted